多参数MRI的ADC指标:经非靶向前列腺穿刺活检诊断的Gleason评分9或10前列腺癌的组织学降级
研究纳入30例经非靶向经直肠超声引导活检诊断为Gleason评分9或10的前列腺癌患者,术前接受3T多参数MRI,评估ADC定量指标对术后组织学降级的预测价值。结果显示30.0%(9/30)患者术后降级为中等风险(Gleason评分7),降级组ADC熵显著低于未降级组(5.542±0.721 vs 8.089±1.237,P<0.001),ADC熵低于6.31时诊断降级的ROC AUC为0.93(95%CI 0.84-1.00),敏感度85.7%、特异度88.9%。
要点
- 经非靶向活检诊断的GS 9或10前列腺癌中,30.0%(9/30)术后降级为GS 7。
- 降级组ADC熵显著低于未降级组(5.542±0.721 vs 8.089±1.237,P<0.001)。
- ADC熵<6.31诊断降级的AUC为0.93(95%CI 0.84-1.00),敏感度85.7%、特异度88.9%。
核心结论
- 经非靶向经直肠超声引导活检诊断的GS 9或10前列腺癌中,术后降级为中等风险(GS 7)者ADC熵显著更低,ADC纹理分析可能有助于进一步风险分层。
研究设计与样本
- 2012年至2015年间30例经非靶向经直肠超声引导活检诊断为GS 9或10前列腺癌的男性,根治性前列腺切除术前接受3T多参数MRI;两名放射科医生盲法独立评估PI-RADS v2,第三名盲法放射科医生从配准的ADC与根治性前列腺切除标本图提取全病灶ADC均值、百分位和纹理特征;采用卡方检验、多变量逻辑回归和ROC分析进行比较。
诊断标准与关键数值
- ADC熵<6.31诊断组织学降级的ROC AUC为0.93(95%CI 0.84-1.00),敏感度85.7%,特异度88.9%。
临床应用与阅片要点
- ADC熵在降级组为5.542±0.721、未降级组为8.089±1.237(P<0.001),ADC均值或百分位两组间无差异(P=0.269-0.634),PI-RADS v2评分两组间无差异(P=0.035、P=0.091)且一致性中等(κ=0.48)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to evaluate quantitative apparent diffusion coefficient (ADC) metrics for the downgrading of Gleason score (GS) 9 or 10 prostate cancer (PCa) diagnosed by means of nontargeted transrectal ultrasound-guided biopsy.
MATERIALS AND METHODS: Between 2012 and 2015, 30 men with a diagnosis of GS 9 or 10 PCa at nontargeted transrectal ultrasound-guided biopsy underwent 3-T multiparametric MRI before radical prostatectomy (RP). Two radiologists blinded to the histopathologic results independently assessed multiparametric MR images using Prostate Imaging Reporting and Data System (PI-RADS) version 2. Whole-lesion ADC mean, centile, and texture features were extracted from coregistered ADC and RP maps by a third blinded radiologist. Comparisons were performed by chi-square, multivariable logistic regression, and ROC analysis.
RESULTS: Tumors were downgraded to intermediate risk (GS 4 + 3 [n = 7] and GS 3 + 4 [n = 2]) PCa in 30.0% (9/30) of men after RP. There were no statistically significant differences between groups with respect to age (p = 0.028), prostate-specific antigen level (p = 0.018), or clinical stage (p = 0.021). PI-RADS version 2 scores did not differ between groups (p = 0.035, p = 0.091) with moderate agreement (κ = 0.48). There were no differences in mean or centile ADC (p = 0.269-0.634) between the two groups. ADC entropy was significantly lower in downgraded tumors (5.542 ± 0.721 [SD] vs 8.089 ± 1.237, p < 0.001) with no difference in kurtosis or skewness (p = 0.133, p = 0.296). The ROC AUC for the diagnosis of downgrading was 0.93 (95% CI, 0.84-1.00) with sensitivity of 85.7% and specificity of 88.9% when entropy was less than 6.31.
CONCLUSION: ADC entropy was significantly lower in GS 9 and 10 tumors diagnosed by means of nontargeted transrectal ultrasound-guided biopsy that were eventually downgraded to intermediate risk (GS 7) after RP. ADC texture analysis may be useful for further risk stratification of PCa diagnosed at biopsy.
引用
- Sadoughi N, Krishna S, McInnes MDF, et al. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy. AJR Am J Roentgenol. 2018. PMID: 29995495. doi:10.2214/AJR.17.18958
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。